Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page displays the completed melanoma clinical trial record, including its study details, results, publications, and individual participant data-sharing information.
    Difference
    82%
    Check dated 2026-11-10T21:35:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T21:48:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice about NIH terminology changes appears above the page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:05:28.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:23:20.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page with the standard header and footer, replacing expected content and including a Home link. This indicates the page cannot be loaded as intended.
    Difference
    0.5%
    Check dated 2026-09-29T22:20:54.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, indicating that access to the record is blocked and the standard header/footer are displayed as part of the error page.
    Difference
    20%
    Check dated 2026-09-22T23:05:30.000Z thumbnail image

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.